Benign prostatic hyperplasia (BPH) is one of the most common conditions affecting aging men, and when medication no longer controls urinary symptoms, patients and their physicians often face a choice between two very different treatment philosophies. Transurethral resection of the prostate (TURP) has been a surgical standard for decades, while prostate artery embolization vs TURP has become a frequent topic of discussion as interventional radiology has matured into a recognized alternative pathway. Neither option is universally "better" — each has a distinct mechanism, recovery profile, and set of clinical considerations.
What Does TURP Actually Remove?
TURP is a surgical procedure performed through the urethra, in which a resectoscope is used to shave away excess prostate tissue that is obstructing urine flow. It is typically performed under spinal or general anesthesia and usually requires a short hospital stay with a urinary catheter in place for a day or more afterward. Because tissue is directly removed, TURP tends to produce a fast and pronounced improvement in urine flow rate for many patients, and it has decades of long-term outcome data behind it.
How Does Prostate Artery Embolization Work Differently?
Prostate artery embolization (PAE) takes an entirely different route. Rather than removing tissue, an interventional radiologist accesses the arterial system — commonly through the wrist or groin — and guides a catheter into the small arteries supplying the prostate gland. Embolic material is then delivered to reduce blood flow to the enlarged tissue, which over time is associated with a reduction in prostate volume and improvement in urinary symptoms. PAE does not require general anesthesia in most cases and is generally performed without an overnight hospital stay in appropriately selected patients.
Recovery Experience: What Differs Day to Day?
Recovery patterns diverge in ways that matter to patients weighing their options.
- TURP recovery commonly involves a catheter for several days, some visible blood in the urine during early healing, and a return to normal activity that clinicians often describe in terms of one to two weeks, though this varies by individual.
- PAE recovery is generally associated with less immediate discomfort and a shorter catheterization period, though symptom improvement tends to build gradually over weeks to months rather than appearing immediately.
- Sexual function considerations differ between the two: TURP carries a recognized association with retrograde ejaculation, while PAE is often discussed as having a different risk profile in this regard — a qualified physician determines suitability based on individual anatomy and goals.
- Retreatment considerations may also differ, and patients should discuss durability expectations directly with their care team rather than assuming either approach is permanent for every individual.
Who Tends to Be Considered for Each Approach?
Prostate size, anatomy of the pelvic arteries, symptom severity, anesthesia risk, and patient preference all factor into which pathway a urology or interventional radiology team recommends. Some men with very large prostates or significant anesthesia risk may be steered toward PAE, while others with anatomy less favorable for arterial access, or a preference for a single definitive procedure with the most established long-term data, may be guided toward TURP. Because both are legitimate options for BPH, the choice is never automatic — a qualified physician determines suitability after evaluating imaging, symptom scores, and the patient's overall health.
Where INVAMED Fits Into Embolization Care
Interventional radiology teams performing arterial embolization procedures, including prostate artery embolization, rely on embolic devices designed for controlled, targeted vessel occlusion. INVAMED manufactures embolization technologies as part of its interventional portfolio; details on the current embolization product range are available on the INVAMED embolization products page. Availability and indications vary by country, and clinicians should always refer to the Instructions for Use (IFU) for specific device applications.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.